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Background: The time course of blood lactate levels could be helpful to assess a patient’s response to therapy.
Although the focus of published studies has been largely on septic patients, many other studies have reported
serial blood lactate levels in different groups of acutely ill patients.
Methods: We performed a systematic search of PubMed, Science Direct, and Embase until the end of February
2016 plus reference lists of relevant publications. We selected all observational and interventional studies that
evaluated the capacity of serial blood lactate concentrations to predict outcome. There was no restriction based
on language. We excluded studies in pediatric populations, experimental studies, and studies that did not report
changes in lactate values or all-cause mortality rates. We separated studies according to the type of patients
included. We collected data on the number of patients, timing of lactate measurements, minimum lactate level
needed for inclusion if present, and suggested time interval for predictive use.
Results: A total of 96 studies met our criteria: 14 in general ICU populations, five in general surgical ICU populations,
five in patients post cardiac surgery, 14 in trauma patients, 39 in patients with sepsis, four in patients with cardiogenic
shock, eight in patients after cardiac arrest, three in patients with respiratory failure, and four in other conditions. A
decrease in lactate levels over time was consistently associated with lower mortality rates in all subgroups of patients.
Most studies reported changes over 6, 12 or 24 hrs, fewer used shorter time intervals. Lactate kinetics did not appear
very different in patients with sepsis and other types of patients. A few studies suggested that therapy could be guided
by these measurements.
Conclusions: The observation of a better outcome associated with decreasing blood lactate concentrations was
consistent throughout the clinical studies, and was not limited to septic patients. In all groups, the changes are
relatively slow, so that lactate measurements every 1–2 hrs are probably sufficient in most acute conditions. The value
of lactate kinetics appears to be valid regardless of the initial value.Background
Since the early studies by Weil and others [1–3], blood
lactate concentrations have been used widely as a
marker of altered tissue perfusion in critically ill patients
[4]. In physiological conditions, about 1500 mmol of
lactate is produced daily from various organs, including
the muscle, the intestine, the red blood cells, the brain,
and the skin [5]. Lactate is metabolized by the liver
(about 60 %), the kidneys (about 30 %), and other organs
[5]. The normal blood lactate concentration is around
1 mEq/l [6]. Even minor increases in lactate concentrations* Correspondence: jlvincent@intensive.org
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[6, 7]. The exact pathophysiologic mechanisms of hyper-
lactatemia have been much debated, because the condi-
tion does not always simply reflect the development of
anaerobic metabolism [8]. In sepsis in particular, metabolic
alterations can contribute to elevated blood lactate concen-
trations, including increased glycolysis, catecholamine-
stimulated Na–K pump activity, alterations in pyruvate
dehydrogenase activity, and reduced lactate clearance
primarily as a result of liver hypoperfusion. Regardless
of these mechanisms, hyperlactatemia is a hallmark
characteristic of shock states [4, 9] and the degree of in-
crease in lactate concentrations is directly related to the
severity of the shock state and to mortality rates [10, 11].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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lactate levels can be the result of increased production,
reduced elimination, or both. A dynamic evaluation of
serial lactate concentrations may thus be more inform-
ative than a single value. This concept of repeating blood
lactate concentrations over time as an indicator of re-
sponse to therapy was first proposed in 1983 [12], based
on an idea raised after a publication by Orringer et al. in
1977 [13] showing that the decrease in lactate levels
after cessation of grand mal seizures was actually quite
rapid, with a half-life of about 50 % in 1 hr. Many stud-
ies have since emphasized that changes in lactate over
the first hrs of treatment may represent a valuable moni-
toring tool. Some studies have even proposed integrating
changes in lactate concentrations as a target in thera-
peutic protocols [14–17] or including them as one of the
sepsis resuscitation “bundles” [18]. A number of investi-
gators have used the term “lactate clearance” to describe
decreasing lactate levels, but this is incorrect for two
reasons. The first is that the changes in lactate concen-
trations over time reflect changes in production and in
elimination. The decrease in lactate over time may re-
flect decreased (over)production more than increased
clearance by the liver and other organs [19, 20]. The spe-
cific study of lactate clearance would require intravenous
injection of radiolabeled lactate, as has been done in sev-
eral studies [21, 22]. The second reason why use of the
term is incorrect is that “clearance” or “elimination” implies
a progressive normalization of blood lactate concentrations,
which is too simplistic. Blood lactate concentrations can
have a complex evolution and may even increase over time
(Fig. 1), a situation that one should then call “negative
lactate clearance”.
We performed a literature search on this subject to
address several questions. First, is the observation of a
better prognosis with decreasing lactate concentrations aFig. 1 Schematic showing some of the possible evolutions of blood lactate
Dashed lines represent an unfavorable course and suggest the need for tre
current management is likely ineffectiveconsistent finding in all types of critically ill patient?
Second, although some studies have suggested that re-
peated lactate measurements may be particularly useful
in sepsis, can similar observations be made in other
acute disease states or even in heterogeneous groups of
critically ill patients? Third, how fast should lactate con-
centrations decrease in optimal conditions and is there
any particular time interval that could be recommended?
Fourth, some studies in emergency medicine considered
only patients with lactate values > 4 mEq/l as an at-risk
population, but is this approach valid? In other words, is
the study of lactate kinetics more useful when lactate
concentrations exceed a given value?
Methods
We searched databases of PubMed, Science Direct, and
Embase until the end of February 2016 to identify studies
that evaluated the capacity of serial blood lactate concen-
trations to predict outcome, using the search terms
“Lactate levels” OR “lactate clearance” AND “shock” OR
“critically ill” AND “mortality”. We included original
prospective or retrospective clinical studies. There was no
restriction based on language. We excluded studies in
pediatric populations, experimental studies, case reports,
and studies that did not report changes over time in
lactate values or relationship of changes in lactate concen-
trations to all-cause mortality rates. We had no restriction
on the initial location in the hospital (e.g., ICU, trauma
unit, emergency room, operating room). We also checked
the reference lists of included articles to capture any refer-
ences missed during the search. We classified the different
adult populations into general ICU patients, general
surgical ICU patients, cardiac surgery patients, trauma
patients, patients with sepsis, patients with cardiogenic
shock, post-cardiac arrest patients, patients with respira-
tory failure, and others.levels over time: decreasing (1), remaining stable (2), or increasing (3).
atment to be reviewed, if this has not already been done, because the
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We identified 13 observational studies in heterogeneous
critically ill populations [6, 10–12, 23–31]. All of these
studies indicated that nonsurvivors had persistently
higher lactate concentrations over time than survivors.
Only one study [26] reported that lactate reduction dur-
ing the first 24 hrs of ICU stay was useful only in septic
patients, but not in patients with hemorrhage or other
conditions.Fig. 2 Prisma diagramThe suggested optimal timing of lactate measurements
was not precisely defined in several of the studies that
evaluated the course of lactate concentrations over time.
The studies that did include a time interval usually
selected 6, 12 or even 24 hrs.
Interventional studies
An interventional trial of 348 patients by Jansen et al. [15]
targeted a lactate decrease of at least 20 % in 2 hrs for the
initial 8 hrs of treatment in ICU patients with an initial
lactate ≥ 3 mEq/l. This strategy was associated with a
lower mortality rate in the lactate-guided therapy group
after adjustment for predefined risk factors (hazard ratio
(HR), 0.61; confidence interval (CI), 0.43–0.87).















1. Vincent, 1983 [12] 17 Prospective ≥4 Every 20 min during
first 2 h of ICU
treatment
1 h Decrease >10 % associated
with survival
2. Cowan, 1984 [23] 30 Prospective – 3 h, 24 h 3 h Change in lactate predictive of
outcome but less so than
simple hemodynamic variables
3. Suistomaa, 2000 [24] 100 Prospective – Every 2 h for 24 h 6 h Failure to decrease lactate at
6 h associated with higher
mortality
4. Jansen, 2008 [31] 106 Prospective – Variable (at
ambulance pickup
and at ER arrival)
— Decrease in lactate
independently associated with
decreased hazard of death
5. Wang, 2009 [25] 101 NR ≥2 12 h, 24 h 12 h Decrease ≤10 % associated
with increased mortality
6. Jansen, 2009 [26] 394 Prospective – 12 h, 24 h 12 h Decrease in lactate only of
prognostic value in patients
with sepsis
7. Krishna, 2009 [27] 50 Prospective – 12 h, 24 h, 36 h 24 h, 36 h Decreasing levels associated
with survival
8. Soliman, 2010 [28] 433 Prospective – 24 h, 48 h 24 h Higher lactate concentrations
at 24 and 48 h after admission
associated with decreased
survival
9. Nichol, 2010 [6] 7155 Retrospective – Variable 24 h Time-weighted average lactate
over 24 h independent
predictor of mortality
10. Nichol, 2011 [10] 5041 Retrospective – Variable 24 h Time-weighted average lactate
and change in lactate over
24 h independent predictors of
hospital mortality
11. van Beest, 2013 [29] 2251 Retrospective – Variable 6 h Normalization of lactate <6 h
after ICU admission associated
with better hospital survival
than normalization of lactate
>6 hrs
12. Zhang, 2014 [30] 6291 Retrospective >2 Variable Variable Normalization and speed of
normalization related to
outcome
13. Haas, 2016 [11] 400 Retrospective >10 Variable 12 h No decrease in lactate over
12 h associated with increased
mortality
Interventional
14. Jansen, 2010 [15] 348 Prospective ≥3.0 2 h 8 h Objective was to decrease
lactate by 20 % or more per
2 h for the initial 8 h of ICU
stay. Lactate-guided therapy
was independently associated
with reduced hospital mortality
Surgical ICU
15. McNelis, 2001 [32] 95 Retrospective – 8-h intervals until
lactate normalized
Variable Time to lactate normalization
predictive of outcome
16. Husain, 2003 [33] 137 Retrospective – Variable Variable Time to lactate normalization
independent predictor of
mortality
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Table 1 Included studies according to population type (Continued)
17. Meregalli, 2004 [34] 44 Prospective – 12 h, 24 h, 48 h 48 h Blood lactate concentrations
decreased with time in




108 Prospective >2 6 h 6 h Decrease in lactate by >40 %
associated with increased
survival
19. Ibrahim, 2013 [36] 322 Prospective – 8 h, 16 h, 24 h 16 h Percent change in blood




20. Lindsay, 2013 [37] 1291 Retrospective – Variable Variable Longer predicted time to reach
normal lactate (<1.5 mmol/l)
associated with increased
mortality
21. Hajjar, 2013 [38] 502 Prospective – 6 h, 12 h 6 h, 12 h Failure to decrease lactate
associated with major
complications, including death
22. Park, 2014 [39] 115 Retrospective – 6 h, 12 h, 24 h 6 h, 12 h,
24 h




2935 Prospective – 6 h, 12 h, 24 h 24 h Later peak in lactate associated
with higher hospital and
long-term mortality
24. Li, 2015 [41] 123 Retrospective – 6 h, 12 h 12 h Lactate decrease predictive of




25. Abramson, 1993 [42] 76 Prospective – 8 h, 16 h, 24 h, 36 h,
48 h
24 h Normalization of lactate by
24 h associated with 100 %
survival
26. Manikis, 1995 [43] 129 Retrospective – At least three times a
day
Variable Duration of hyperlactatemia
correlated with the
development of organ failure
but not with mortality
27. Holm, 2000 [44] 21 Prospective – 12 h, 24 h, 48 h, 72 h Variable Decreasing lactate levels
associated with survival
28. Cerovic, 2003 [45] 98 Prospective – Twice daily during
first 2 days and once
daily during next
3 days
Variable Reduced lactate levels in
survivors
29. Kamolz, 2005 [46] 166 Prospective – Variable 24 h Higher mortality in patients
with initial lactate > 2 mmol/l if
lactate not normalized at 24 h









724 Retrospective – Variable Variable In patients without traumatic
brain injury, decrease in lactate
impaired in nonsurvivors
33. Odom, 2013 [50] 623 Retrospective ≥4 6 h 6 h Lower decrease in lactate at
6 h independently predictive of
increased risk of death
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34. Heinonen, 2014 [51] 610 Retrospective – Variable Variable Failure to normalize lactate
associated with increased
mortality
35. Freitas, 2015 [52] 117 Retrospective – 6 h 6 h No correlation between
decrease in lactate and
mortality




37. Blow, 1999 [55] 79 Retrospective – Variable 24 h Failure to decrease lactate
associated with increased
mortality
38. Claridge, 2000 [56] 364 Prospective – Variable 12 h Increase in infections, length of
stay, and mortality if lactate did
not normalize by 12 h
Sepsis
Observational
39. Bakker, 1991 [57] 48 Prospective >2 Variable Variable Only survivors had a significant
decrease in blood lactate
concentrations during the
course of septic shock
40. Friedman, 1995 [58] 35 Prospective >2 4 h, 24 h Variable Lactate remained high in
nonsurvivors and progressively
decreased in survivors
41. Bernardin, 1996 [59] 32 Prospective – 24 h 24 h Greater decrease in lactate in
survivors
42. Marecaux, 1996 [60] 38 Prospective >2 24 h, 48 h 24 h, 48 h Greater decrease in lactate in
survivors
43. Bakker, 1996 [61] 87 Prospective >2 Variable Variable Duration of lactic acidosis best
discriminant of survival
44. Kobayashi, 2001 [62] 22 Prospective – Every 4 hours for
4 days
Variable Decrease in lactate associated
with survival
45. Nguyen, 2004 [63] 111 Prospective – 6 h 6 h Decrease in lactate ≥10 %
associated with lower 60-day
mortality
46. Nguyen, 2007 [64] 330 Prospective – Variable 6 h Decreased odds ratio for
mortality in patients with
decreased lactate
47. Phua, 2008 [65] 72 Prospective – 24 h, 48 h 24 h Increase in lactate predictive of
mortality
48. Yang, 2009 [66] 105 Prospective – 6 h, 24 h, 72 h 6 h Decrease in lactate at 6 h
≥30 % was independent
predictor of survival
49. Arnold, 2009 [67] 166 Retrospective – 6 h 6 h Lactate decrease by less than
10 % independent predictor of
in-hospital death
50. Nguyen, 2010 [68] 220 Retrospective – 6 h 6 h Larger decrease in lactate
associated with decreased
mortality up to 12 months
51. Nguyen, 2011 [18] 556 Prospective – 12 h 12 h Any decrease in lactate within




52. Puskarich, 2012 [69] 203 Retrospective
analysis of data
from [16]
– 2 h, 4 h, 6 h 6 h ≥10 % decrease in lactate
during resuscitation associated
with decreased mortality
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53. Zanaty, 2012 [70] 53 Prospective – 6 h 6 h <15 % decrease in lactate
independent predictor of
mortality
54. Puskarich, 2013 [71] 187 Retrospective
analysis of data
from [16]
– At least two lactate
measurements in first
6 h
6 h Lactate normalization in 6 h
stronger independent predictor
of survival than decrease in
lactate by ≥50 %
55. Walker, 2013 [72] 78 Retrospective – 6 h 6 h Decrease in lactate
independently associated with
mortality, with optimal cut-off
of 36 %
56. Liu, 2013 [73] 9190 Retrospective ≥2 4 h, 8 h, 12 h 12 h Reduced mortality in patients
with more than 60 % lactate
improvement at 12 h.
57. Marty, 2013 [74] 94 Prospective – 6 h, 12 h, 24 h 24 h Decrease in lactate at 24 h
independently correlated to
survival
58. Park, 2014 [75] 25 Prospective – 6 h, 12 h, 18 h, 24 h,
48 h
48 h Normalization independent
predictor of survival
59. Permpikul, 2014 [76] 51 Prospective – 6 h 6 h Lactate decrease associated
with reduced 28-day mortality
60. Bao, 2015 [77] 94 Retrospective – 3 h, 6 h, 24 h 24 h 24-h lactate decrease predictive
of outcome
61. Galbois, 2015 [78] 42 Prospective – 6 h, 12 h, 18 h, 24 h 6 h Lesser decrease in lactate
associated with 14-day
mortality
62. Lee, 2015 [79] 109 Retrospective >3.3 6 h, 24 h, 48 h 6 h, 24 h,
48 h
Decrease in lactate of <10 % in
the first 6 h, 24 h, and 48 h
independently associated with
mortality





74 Retrospective ≥4 Variable Variable Lactate decrease < 4 mmol/l
associated with increased
hospital morality
65. Wang, 2015 [81] 115 Prospective – 6 h, 12 h, 18 h, 24 h 24 h Lower lactate area score and
percentage decrease in lactate
associated with increased
mortality
66. Bhat, 2015 [82] 207 Retrospective – Variable Variable Higher mortality in patients
with no decrease in lactate
67. Chertoff, 2016 [83] 229 Retrospective – 24-48 h 24-48 h Lower decrease in plasma
lactate 24–48 h after initiation
of treatment was associated
with higher 30-day mortality
68. Drumheller, 2016 [84] 411 Retrospective ≥4 Variable Variable Decrease in lactate
independently associated with
decreased risk of death
69. He, 2016 [85] 84 Prospective – 8 h 8 h Patients with lactate decrease
≥10 % had lower ICU mortality
than those with lactate
decrease <10 %
70. Ha, 2016 [86] 208 – 6 h, 24 h 24 h Low decrease in lactate at 6
and 24 h independently
associated with hospital
mortality, but 24-h lactate
decrease had higher
discriminatory power
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71. Bolvardi, 2016 [87] 90 Prospective – 6 h 6 h Lactate decrease <10 %
associated with increased
mortality
72. Amir, 2016 [88] 202 Prospective – 6 h 6 h Lactate decrease ≥10 % not
associated with mortality
Interventional
73. Jones, 2010 [16] 300 Prospective – Variable Variable No differences in in-hospital
mortality using management
to normalize lactate compared
with management to normalize
ScvO2
74. Tian, 2012 [89] 62 Prospective – Variable 48 h 28-day mortality rates lower in
patients with 30 % decrease in
lactate target than in those
with 10 % decrease in lactate
target and controls
75. Yu, 2013 [90] 50 Prospective – 3 h, 6 h, 72 h 6 h, 72 h No differences in in-hospital
mortality using management
targeted at 10 % lactate decrease
compared with management to
normalize ScvO2
76. Lyu, 2015 [91] 100 Prospective – 1 h, 2 h, 3 h, 4 h, 5 h,
6 h
6 h 28-day mortality independently
associated with lactate
decrease <10 %




78. Attana, 2012 [93] 51 Prospective – 12 h 12 h Decrease in lactate by <10 %
predicts higher risk of death
79. Attana, 2013 [94] 63 Prospective – 12 h 12 h Nonsurvivors had smaller
decrease in lactate
80. Park, 2014 [95] 96 Retrospective – Variable 48 h Lactate decrease <70 %
independent predictor of
hospital mortality
81. Guenther, 2014 [96] 41 retrospective – Variable 6 h Increased lactate




82. Kliegel, 2004 [97] 394 Retrospective – 24 h, 48 h 48 h Persistent hyperlactatemia
predictive or poor prognosis
83. Donnino, 2007 [98] 79 Retrospective – 6 h, 12 h 12 h Decrease in lactate
independent predictor of
hospital survival
84. Arnalich, 2010 [99] 85 Prospective – 6 h 6 h Decrease in lactate significantly
higher in 24-h survivors com-
pared with nonsurvivors
85. Le Guen, 2011 [100] 51 Prospective – 1 h 1 h Decrease in blood lactate
>10 % significantly different in
survivors and nonsurvivors
treated with ECMO
86. Starodub, 2013 [101] 199 Retrospective – 6 h, 12 h, 24 h 12 h, 24 h Change in lactate over time
not predictive of survival but
lower mean lactate levels at 12
and 24 h associated with
increased survival
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87. Donnino, 2014 [102] 100 Prospective – 12 h, 24 h 12 h Greater percentage decrease
independently associated with
survival
88. Riveiro, 2015 [103] 54 Prospective – 6 h, 12 h, 24 h,
48 h, 72 h
6 h Decrease in lactate predictive
of 28-day survival
89. Williams, 2016 [104] 167 Retrospective – Variable 4 h More rapid decrease in lactate
in survivors
Respiratory failure
90. Zhao, 2010 [105] 110 Prospective – 6 h 6 h Lactate decrease ≥10 %
associated with improved
survival
91. Wu, 2012 [106] 27 Prospective – 12 h, 24 h, 48 h, 72 h 12 h, 24 h,
48 h, 72 h
Smaller decrease in lactate
predictive of outcome
92. Zang, 2014 [107] 43 Prospective – 6 h 6 h Decrease in lactate
independent predictor of
survival in patients treated
by ECMO
Others
93. Scott, 2010 [110] 95 Prospective – 1 h, 2 h, 6 h, 24 h 2 h Lactate decrease <15 %





94. Wu, 2011 [109] 222 Prospective – 6 h 6 h Lactate decrease of <24.8 % at
6 h associated with higher
incidence of liver graft failure
and mortality
95. Lui, 2013 [108] 204 Prospective ≥2 12 h 12 h Smaller decrease in lactate
associated with increased
mortality in patients with
paraquat poisoning
96. Mohamed, 2014 [111] 46 Prospective – 8 h, 24 h 24 h Mortality greater if <40 %
decrease in lactate
EMCO extracorporeal membrane oxygenation, ER emergency room, h hours, NR not reported, ScvO2 central venous oxygen saturation
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We identified five observational studies conducted in
general surgical ICU patients [32–36]. Failure of lactate
concentrations to decrease over time was associated with
worse outcomes in all studies.
After cardiac surgery
There were five observational studies in cardiac surgery
patients [37–41], including two studies in patients
treated with extracorporeal membrane oxygenation
(ECMO) post cardiac surgery [39, 41]. All studies con-
sistently demonstrated differences in changes in lactate
concentration between survivors and nonsurvivors.
Trauma patients
Observational studies
We identified twelve observational studies in trauma
patients [42–53]. Three retrospective studies reported no
association of change in lactate levels with mortality
[43, 47, 52], although Manikis et al. [43] reported thatthe duration of hyperlactatemia was associated with the
development of organ failure and Billeter et al. [47] noted
that delayed or no reduction in blood lactate was associ-
ated with increased infectious complications. Several small
studies used relatively long time intervals of 12–24 hrs
[45, 54]. One study reported that repeated lactate after
2 hrs could be valuable [48] and a retrospective study pro-
posed a time limit of 6 hrs [50].
Interventional studies
In a retrospective analysis of a small prospective cohort
managed according to a protocol to normalize blood
lactate levels, Blow et al. [55] reported that failure to
normalize blood lactate levels (<2.5 mmol/l) was associ-
ated with increased morbidity and mortality. In an
interventional study by Claridge et al. [56], patients were
managed according to the same protocol targeted at re-
ducing lactate levels to <2.4 mmol/l. Failure to achieve
this target was associated with increased risk of infec-
tion, increased length of stay, and increased mortality.
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Observational studies
We found thirty four observational studies in patients
with sepsis [17, 18, 57–88]. One study reported that a
decrease in lactate levels of ≥10 % was not associated
with mortality [88], but this study was conducted in a
low-resource setting, such that resuscitation may not
have been optimal as acknowledged by the authors.
Several studies reported that 6-hrly changes could be a
useful guide [63, 64, 66, 67, 69–72, 78].
Interventional studies
One interventional study by Jones et al. [16] compared
resuscitation based on lactate concentrations with a
target of obtaining a >10 % decrease from the initial
value with resuscitation based on achieving central
venous oxygen saturation (ScvO2) ≥ 70 %; there were no
differences in outcome between the two strategies. In an
analysis of patients in this trial who had simultaneous
lactate and ScvO2 measurements, Puskarich et al. [69]
concluded that failure to achieve the target lactate de-
crease was associated with a worse prognosis than fail-
ure to achieve the ScvO2 target. In a small Chinese
study [89], patients randomized to a 30 % decrease in
lactate target had better 28-day survival than those ran-
domized to a 10 % target or to control, and in another
small study [90] there were no differences in in-hospital
mortality using management targeted at a 10 % decrease
in lactate compared with management to normalize
ScvO2. Two other Chinese studies reported that patients
randomized to lactate-directed therapy had improved
outcomes [91, 92].
Patients with cardiogenic shock
There were four studies in patients with cardiogenic
shock [93–96], all showing that lactate concentrations
decreased more in survivors than in nonsurvivors.
After cardiac arrest
We identified eight observational studies [97–104] in
post-cardiac arrest patients. All but one [101] of these
studies demonstrated differences in changes in lactate
concentration between survivors and nonsurvivors.
Patients with acute respiratory failure
We found three observational studies in patients with
acute respiratory failure [105–107], all showing that
decreasing lactate levels were predictive of survival.
Other conditions
Changes in lactate concentrations were also reported
following paraquat poisoning [108], after liver trans-
plantation [109], in patients with acute cardiorespiratory
failure [110], and in patients with severe community-acquired pneumonia [111]. All studies indicated the
value of repeated lactate concentrations in these patient
populations.
Discussion
Our literature review clearly supports the value of serial
lactate measurements in the evaluation of critically ill
patients and their response to therapy. This observation
was similar across all studies and in all categories of
patients, without being restricted to those with sepsis.
We found only one study which suggested that evaluat-
ing the time course of lactate concentrations would be
useful in sepsis patients but not in other conditions
[26], and just five studies reporting no predictive
effect of decrease in lactate levels over time on mortality
[43, 47, 52, 88, 101] although two of these did suggest a
relationship with morbidity outcomes [43, 47]. Re-
peated lactate concentrations can also help separate
patients with complications, such as neurological
complications after cardiac arrest [112, 113] or after
surgery [38]. A meta-analysis of these data is compli-
cated by the heterogeneity of the populations and the
different timings of the measurements, but the data
are very consistent across studies.
Increased lactate concentrations can be due to factors
other than cellular hypoxia, so the decrease in blood
lactate concentrations may not just be the result of
improvements in cellular oxygen availability. For
example, beta-adrenergic stimulation may contribute to
increased lactate production [114]. A recent study indi-
cated the reverse phenomenon; that is, the increase in
lactate concentrations seen in patients with sepsis may
be blunted in patients previously treated with beta-
blocking agents [115]. The infusion of lactate-containing
intravenous solutions may also potentially complicate
the interpretation of blood lactate concentrations [116],
although the amount of fluid infused must be very large
to have such an effect [117]. A recent study also
reported that lactate levels decrease more slowly in
patients with a positive blood alcohol level, thus compli-
cating evaluation of blood lactate levels in these
patients [118].
Because lactate is primarily metabolized in the liver,
liver dysfunction may alter lactate clearance. Thus,
some studies have questioned whether blood lactate
concentrations can be used to indicate tissue hypo-
perfusion in critically ill patients with hepatic
dysfunction. However, patients with stable cirrhosis
have normal lactate concentrations [8]. Kruse et al.
[119] analyzed the incidence of hyperlactatemia in
patients with liver disease and showed that lactic
acidosis was associated with clinical evidence of shock
and increased hospital mortality. Chiolero et al. [120]
reported that major hepatectomy was not associated
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though lactate half-life was prolonged. A recent ex-
perimental study indicated that liver hypoperfusion
is unlikely to contribute to increased blood lactate
concentrations [121]. In patients with paracetamol-
induced acute liver failure, higher lactate concentra-
tions were associated with more severe organ failure
and mortality [122].
Some investigators have compared lactate and ScvO2
or combined the two measures. Lactate is usually a
better prognostic marker [69]. But is it actually necessary
to choose? In an interventional study in patients with
sepsis, Jones et al. [16] reported no differences in out-
comes for patients managed according to lactate concen-
trations or to ScvO2 values, but it is difficult to evaluate
how these measurements really guided therapy because
there were no differences in administered treatments
during the first 72 hrs. In post-cardiac surgery patients,
Polonen et al. [14] reported better outcomes when
ScvO2 and lactate concentrations were targeted together
than in control patients. The most convincing evidence
in favor of lactate as a target comes from the study by
Jansen et al. [15] in which outcomes were improved in
patients treated to a target of a 20 % decrease in lactate
concentrations. Nevertheless, the relatively slow changes
in lactate make it difficult to interpret these results—the
trend analysis is more a marker of effective treatment
than a target in itself.
Although changes in blood lactate kinetics were clearly
significant after 6 hrs in many studies and after 12 hrs in
most, it is currently not possible to define the best time
interval between lactate measurements. The normal re-
duction in lactate concentrations when overproduction
of lactate abruptly ceases after grand mal seizures is
about 50 % in 1 hr [13]. Although Levraut et al. [21] sug-
gested that lactate clearance may be decreased in septic
patients, Revelly et al. [22] reported similar values in pa-
tients with sepsis and in healthy volunteers.
The rate of lactate decrease in optimal treatment
conditions is quite variable. In the best conditions,
blood lactate concentrations decreased by more than
10 % in 1 hr in patients who responded rapidly to re-
suscitation [12] or by 10–20 % in 2 hrs [15]. A study
by Hernandez et al. [123] suggested a >50 % decrease
in lactate concentrations during the first 6 hrs of re-
suscitation in patients with septic shock. Although
some systems now allow the quasi-continuous meas-
urement of lactate concentrations, determinations
every 1–2 hrs are probably sufficient; in the interven-
tional study by Jansen et al. [15] the protocol was to
measure blood lactate every 2 hrs. Even though serial
blood lactate concentrations have been suggested to
guide therapy, our review underlines that changes in
lactate over time are relatively slow, taking place overhrs, and this may be too slow to guide therapy. Serial
lactate concentrations should serve as a regular con-
trol, similar to how in the past a navigator would
consult a compass from time to time to ensure that
their boat was still heading in the right direction. If
lactate concentrations do not normalize over time,
the need for changes in therapy should be considered.Conclusion
Our systematic literature review has provided the
following answers to our initial questions. First, obser-
vation of a better prognosis with decreasing lactate
concentrations is consistent throughout the literature.
Second, these observations are not specific to septic
patients, but apply to all common situations of hyper-
lactatemia and in heterogeneous patient populations.
Third, the changes are relatively slow, and it is
difficult to provide recommendations about the speed
of decrease in lactate concentrations in the best con-
ditions. Clearly repeating measurements every 12 hrs
can generally separate those who will do well from
those who are likely to die, but shorter time intervals
may be helpful. On the basis of our observations, we
would recommend checking blood lactate concentra-
tions as often as every 1–2 hrs in acute conditions.
Fourth, the study of lactate kinetics appears to be
valid regardless of the initial value and not only in
patients with severe hyperlactatemia.
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